Mother Jones: Inside the secret working group that helped push anti-trans laws across the country
Ryan Thoreson, assistant professor of law at the University of Cincinnati College of Law, spoke to Mother Jones magazine about the development of transgender healthcare bans led by members of the religious-right networks. Leaked emails shows how proponents of the national movement to restrict gender-affirming care for minors successful established a strategy playbook for their attacks.
In the article “Inside the Secret Working Group that Helped Push Anti-Trans Laws Across the Country,” Thoreson discussed South Dakota Republican state Rep. Fred Deutsch’s position as one of the most prominent state lawmakers nationally pushing anti-transgender restrictions early on, well before the popularity of today’s large numbers of bills.
Featured image at top: Rainbow colored sign showing LGBTQ inclusiveness. Photo/iUnsplash.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.